Issue 1/2025
Content (39 Articles)
Bystanders or active players: the role of extra centrosomes as signaling hubs
- Open Access
- REVIEW
Madison M. Purkerson, Sarah R. Amend, Kenneth J. Pienta
A possible role of plasmin-dependent activation of TGF-β in cancer-associated thrombosis: Implications for therapy
- Open Access
- Anticoagulant
- Mini Review
Marta Smeda, Ebrahim H. Maleki, Agnieszka Jasztal
KIF18A inhibition: the next big player in the search for cancer therapeutics
- REVIEW
Ain Syafiza Mohd Amin, Sarah Eastwood, Courtney Pilcher, Jia Q. Truong, Richard Foitzik, Joanne Boag, Kylie L. Gorringe, Jessica K. Holien
Vaping and tumor metastasis: current insights and progress
- Metastasis
- MINI REVIEW
Yibo Xi, Lei Yang, Barbara Burtness, He Wang
Small cell lung cancer with liver metastases: from underlying mechanisms to treatment strategies
- SCLC
- Review
Linjie Fan, Yiwen Lin, Yunjie Fu, Jie Wang
Cell-cell interactions mediating primary and metastatic breast cancer dormancy
- Breast Cancer
- Review
Nicholas A. Lenart, Shreyas S. Rao
Retraction Note: EET signaling in cancer
- Retraction Note
Dipak Panigrahy, Emily R. Greene, Ambra Pozzi, Dao Wen Wang, Darryl C. Zeldin
Tissue-engineered patient-derived osteosarcoma models dissecting tumour-bone interactions
- Open Access
- Osteosarcoma
- REVIEW
Tina Frankenbach-Désor, Isabella Niesner, Parveen Ahmed, Hans Roland Dürr, Alexander Klein, Thomas Knösel, Jonathan Gospos, Jacqui A. McGovern, Dietmar W. Hutmacher, Boris M. Holzapfel, Susanne Mayer-Wagner
Melanoma in people living with HIV: Immune landscape dynamics and the role of immuno- and antiviral therapies
- Open Access
- Human Immunodeficiency Virus
- REVIEW
Lindsay N. Barger, Olivia S. El Naggar, Binh Ha, Gabriele Romano
Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities
- Open Access
- Solid Tumor
- REVIEW
Eleanor C. Smith, Bryan T Mott, Emily Douglas, Stephen B. Tatter, Kounosuke Watabe
The roles of periostin derived from cancer-associated fibroblasts in tumor progression and treatment response
- Metastasis
- REVIEW
Yasmin De Oliveira Macena, Maria Eduarda Nunes Cezar, Cinthya Brunelly Ferreira Lira, Laryssa Bheatriz Dantas Machado De Oliveira, Thais Noronha Almeida, Ana Dora Alecio Virtuoso Costa, Bernardo Mansur Dantas De Araujo, Durval de Almeida Junior, Henrique Macêdo Dantas, Emanuel Cézar De Mélo, Sandra Taveiros de Araújo, Raimundo Rodrigues de França Júnior, Maria Amélia dos Santos Lemos Gurgel, Carlos Alberto de Carvalho Fraga
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms
- CAR T-Cell Therapy
- REVIEW
Tyce J. Kearl, Fateeha Furqan, Nirav N. Shah
Ribosomal rodeo: wrangling translational machinery in gynecologic tumors
- Open Access
- Ovarian Cancer
- REVIEW
Kamil Filipek, Marianna Penzo
CAR T-cell therapy to treat multiple myeloma: current state and future directions
- CAR T-Cell Therapy
- REVIEW
Siddhartha Thammineni Reddy, Hitomi Hosoya, Lekha Mikkilineni
Correlative studies reveal factors contributing to successful CAR-T cell therapies in cancer
- REVIEW
Catherine D. Yao, Kara L. Davis
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond
- Open Access
- Pancreatic Cancer
- Review
Qitong Wu, Deeptashree Nandi, Dipali Sharma
Evolving strategies for addressing CAR T-cell toxicities
- Open Access
- CAR T-Cell Therapy
- REVIEW
Alexander W. Rankin, Brynn B. Duncan, Cecily Allen, Sara K. Silbert, Nirali N. Shah
Influence of antibody–drug conjugate cleavability, drug-to-antibody ratio, and free payload concentration on systemic toxicities: A systematic review and meta-analysis
- Open Access
- Breast Cancer
- REVIEW
Shou-Ching Tang, Carrie Wynn, Tran Le, Martin McCandless, Yunxi Zhang, Ritesh Patel, Nita Maihle, William Hillegass
Homologous recombination deficiency (HRD) diagnostics: underlying mechanisms and new perspectives
- REVIEW
Andrey Kechin, Maksim Koryukov, Regina Mikheeva, Maksim Filipenko
Recapitulating the potential contribution of protein S-palmitoylation in cancer
- REVIEW
Suchi Chaturvedi, Avinash Sonawane
Neuropeptide Y in cancer—biological functions and potential clinical implications
- Open Access
- Metastasis
- REVIEW
Dawid Sigorski, Aleksandra Sejda, Nouran Abualsaud, Ewa Krawczyk, Ewa Izycka-Swieszewska, Joanna Kitlinska
LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance
- Open Access
- Metastasis
- REVIEW
Wanqi Wang, Noor A. Lokman, Simon C. Barry, Martin K. Oehler, Carmela Ricciardelli
Advancements in gene therapies targeting mutant KRAS in cancers
- Open Access
- Gene Therapy
- REVIEW
Yuhang Wang, Thuy Anh Bui, Xinpu Yang, Gyorgy Hutvagner, Wei Deng
Sympathetic nerve signaling rewires the tumor microenvironment: a shift in “microenvironmental-ity”
- Open Access
- REVIEW
Ariana Sattler, Tetiana Korzun, Kasmira Gupta, Parham Diba, Natasha Kyprianou, Sebnem Ece Eksi
The diversity of natural killer cell functional and phenotypic states in cancer
- REVIEW
Kumar Rishabh, Sandro Matosevic
Cellular plasticity and non-small cell lung cancer: role of T and NK cell immune evasion and acquisition of resistance to immunotherapies
- NSCLC
- REVIEW
Sarra Mestiri, Ana Sami, Naresh Sah, Dina Moustafa Abo El-Ella, Sabiha Khatoon, Khadija Shafique, Afsheen Raza, Darin Mansor Mathkor, Shafiul Haque
Efficacy of innovative systemic treatments in combination with radiotherapy for bone metastases: a GEMO (the European Study Group of Bone Metastases) state of the art
- Open Access
- Radiotherapy
- REVIEW
Anna Gueiderikh, Jean-Christophe Faivre, Constance Golfier, Alexandre Escande, Sébastien Thureau
Minimally invasive biomarkers for triaging lung nodules—challenges and future perspectives
- Open Access
- Biomarkers
- REVIEW
Waqar Ahmed Afridi, Samandra Hernandez Picos, Juliana Muller Bark, Danyelle Assis Ferreira Stamoudis, Sarju Vasani, Darryl Irwin, David Fielding, Chamindie Punyadeera
Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy
- NSCLC
- REVIEW
Maritza Ramos-Ramírez, Enrique Caballe-Pérez, José Lucio-Lozada, Eunice Romero-Nuñez, Cesar Castillo-Ruiz, Lorena Dorantes-Sánchez, Diana Flores-Estrada, Gonzalo Recondo, Pedro Barrios-Bernal, Luis Cabrera-Miranda, Heyman Bravo-Dominguez, Norma Hernández-Pedro, Oscar Arrieta
Neuronal mimicry in tumors: lessons from neuroscience to tackle cancer
- Open Access
- Metastasis
- MINI REVIEW
Hanan Bloomer, Haley B. Dame, Savannah R. Parker, Madeleine J. Oudin
CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting
- Breast Cancer
- REVIEW
Priya Ghosh, Ankita Dey, Suvendu Nandi, Ranabir Majumder, Subhayan Das, Mahitosh Mandal
p62/SQSTM1 in cancer: phenomena, mechanisms, and regulation in DNA damage repair
- Open Access
- Esophageal Cancer
- REVIEW
Xiaojuan Yang, Xunjie Cao, Qing Zhu
Mitochondrial alterations and signatures in hepatocellular carcinoma
- Open Access
- Hepatocellular Carcinoma
- REVIEW
Tsung-Hsien Chen, Shu-Hsien Lin, Ming-Yang Lee, Hsiang-Chen Wang, Kun-Feng Tsai, Chu-Kuang Chou
Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis
- Open Access
- Checkpoint Inhibitors
- REVIEW
Aiarpi Ezdoglian, Michel Tsang-A-Sjoe, Fatemeh Khodadust, George Burchell, Gerrit Jansen, Tanja de Gruijl, Mariette Labots, Conny J. van der Laken
Epigenetic drugs in cancer therapy
- Open Access
- Epigenetics
- REVIEW
Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard
The functions and modifications of tRNA-derived small RNAs in cancer biology
- Biomarkers
- REVIEW
Abdulaziz Ahmed A. Saad, Kun Zhang, Qianqian Deng, Jiawang Zhou, Lichen Ge, Hongsheng Wang
Using ultrasound and microbubble to enhance the effects of conventional cancer therapies in clinical settings
- Open Access
- Cytostatic Therapy
- MINI REVIEW
Deepa Sharma, Gregory J. Czarnota
